Korean Circulation Journal

The Korean Society of Cardiology (대한심장학회)
권호 표지
DOI QR코드

DOI QR Code

Prevalence of Echocardiographic Features Suggesting Cardiac Sarcoidosis in Patients With Pacemaker or Implantable Cardiac Defibrillator

  • Sun, Byung-Joo (Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Lee, Pil-Hyung (Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Choi, Hyung-Oh (Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Ahn, Jung-Min (Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Seo, Jeong-Sook (Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Dae-Hee (Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Song, Jong-Min (Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Choi, Kee-Joon (Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kang, Duk-Hyun (Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Song, Jae-Kwan (Division of Cardiology, Asan Medical Center, University of Ulsan College of Medicine)
  • Published : 2011.06.30
⟨ Previous Next ⟩

Abstract

Background and Objectives: Basal septal thinning or localized aneurysmal dilatation without coronary artery disease has been described as a characteristic finding suggestive of cardiac sarcoidosis. We sought to assess the prevalence of this characteristic echocardiographic finding in patients with pacemaker (PM) or implantable cardiac defibrillator (ICD). Subjects and Methods: Echocardiography of patients who received PM or ICD were retrospectively analyzed. Patients with marked thinning and akinesia confined to the basal septum (type 1), or posterolateral wall resulting in localized aneurysmal outward bulging (type 2) without history of myocardial infarction or significant coronary stenosis were included for analysis. Results: Among 1,357 consecutive patients, 21 exhibited suggestive echocardiographic findings (type 1/2=15/6) with a mean ejection fraction of 37${\pm}$11%. The prevalence was 1.2% in the PM group and 4.0% in the ICD group. Only 3 patients showed histologically confirmable sarcoidosis in lymph nodes, lung and heart, respectively. Endomyocardial biopsy was attempted in 6 patients, but failed to demonstrate sarcoidosis. The 1-, 2-, 4- and 6-year clinical events (death, cardiac transplantation and hospital admission)-free survival rates were 100%, 85.7${\pm}$7.6%, 75.0${\pm}$9.7% and 48.6${\pm}$12.4%, respectively. During follow-up, two patients with PM underwent ICD implantation, and another underwent heart transplantation. Conclusion: Prevalence of echocardiographic features suggesting prevalence of cardiac sarcoidosis is low in patients who underwent device implantation. However, considering the very low yield of endomyocardial biopsy and the rare extracardiac manifestations in cardiac sarcoidosis, characteristic echocardiographic findings could be an adjunctive diagnostic criterion in these patients.

Keywords

References

  1. Dubrey SW, Bell A, Mittal TK. Sarcoid heart disease. Postgrad Med J 2007;83:618-23 https://doi.org/10.1136/pgmj.2007.060608
  2. Bargout R, Kelly RF. Sarcoid heart disease: clinical course and treatment. Int J Cardiol 2004;97:173-82. https://doi.org/10.1016/j.ijcard.2003.07.024
  3. Sekiguchi M, Yazaki Y, Isobe M, Hiroe M. Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations. Cardiovasc Drugs Ther 1996;10:495-510. https://doi.org/10.1007/BF00050989
  4. Lewin RF, Mor R, Spitzer S, Arditti A, Hellman C, Agmon J. Echocardiographic evaluation of patients with systemic sarcoidosis. Am Heart J 1985;110:116-22. https://doi.org/10.1016/0002-8703(85)90524-1
  5. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med 1977;63:86-108. https://doi.org/10.1016/0002-9343(77)90121-8
  6. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoido-sis. Circulation 1978;58:1204-11. https://doi.org/10.1161/01.CIR.58.6.1204
  7. Yamano T, Nakatani S. Cardiac sarcoidosis: what can we know from echocardiography? J Echocardiogr 2007;5:1-10. https://doi.org/10.2303/jecho.5.1
  8. Hiraga H, Yuwai K, Hiroe M. Guidelines for the diagnosis of cardiac sarcoidosis: study report of diffuse pulmonary diseases. Tokyo: Japanese Ministry of Health and Welfare;1993. p.23-4.
  9. Tawarahara K, Kurata C, Okayama K, Kobayashi A, Yamazaki N. Thallium-201 and gallium 67 single photon emission computed tomographic imaging in cardiac sarcoidosis. Am Heart J 1992;124:1383-4. https://doi.org/10.1016/0002-8703(92)90431-T
  10. Tellier P, Paycha F, Antony I, et al. Reversibility by dipyridamole of thallium-201 myocardial scan defects in patients with sarcoidosis. Am J Med 1988;85:189-93. https://doi.org/10.1016/S0002-9343(88)80340-1
  11. Rybicki BA, Major M, Popovich J, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997;145:234-41. https://doi.org/10.1093/oxfordjournals.aje.a009096
  12. Kim DS. Sarcoidosis in Korea: report of the Second Nationwide Sur-vey. Sarcoidosis Vasc Diffuse Lung Dis 2001;18:176-80.
  13. Matsui Y, Iwai K, Tachibana T, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci 1976;278:455-69. https://doi.org/10.1111/j.1749-6632.1976.tb47058.x
  14. Siltzbach LE, James DG, Neville E, et al. Course and prognosis of sar-coidosis around the world. Am J Med 1974;57:847-52. https://doi.org/10.1016/0002-9343(74)90160-0
  15. Choi JH, Kim J, Park TI, et al. Two cases of an implantation of a per-manent pacemaker using a transaxillary incision. Korean Circ J 2008; 38:500-4. https://doi.org/10.4070/kcj.2008.38.9.500
  16. Uemura A, Morimoto S, Hiramitsu S, Kato Y, Ito T, Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J 1999;138:299-302. https://doi.org/10.1016/S0002-8703(99)70115-8
  17. Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H Jr. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Stu-dy of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:75-86.
  18. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007;357:2153-65. https://doi.org/10.1056/NEJMra071714
  19. Nelson JE, Kirschner PA, Teirstein AS. Sarcoidosis presenting as heart disease. Sarcoidosis Vasc Diffuse Lung Dis 1996;13:178-82.
  20. Chiu CZ, Nakatani S, Zhang G, et al. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol 2005;95:143-6. https://doi.org/10.1016/j.amjcard.2004.08.083
  21. Valantine H, McKenna WJ, Nihoyannopoulos P, et al. Sarcoidosis: a pattern of clinical and morphological presentation. Br Heart J 1987; 57:256-63. https://doi.org/10.1136/hrt.57.3.256
  22. Cho Y. Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Korean Circ J 2008;38:514-23. https://doi.org/10.4070/kcj.2008.38.10.514

Cited by

  1. Cardiac sarcoidosis: A review on the work-up and management vol.8, pp.1, 2011, https://doi.org/10.2478/s11536-012-0095-8
  2. Improving the diagnostic accuracy for detecting cardiac sarcoidosis vol.13, pp.2, 2011, https://doi.org/10.1586/14779072.2015.1001367
  3. The Multi-modality Cardiac Imaging Approach to Cardiac Sarcoidosis vol.15, pp.1, 2011, https://doi.org/10.2174/1573405614666180522074320